{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["751ebd2d-e086-4c61-8bff-ca32dd4edd63", "Q4", 400577737, "THE INGRAM GROUP LLC", 193009, "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)", 2012, "fourth_quarter", "2013-01-19T22:13:20.820000-05:00", 60000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/751ebd2d-e086-4c61-8bff-ca32dd4edd63/\", \"filing_uuid\": \"751ebd2d-e086-4c61-8bff-ca32dd4edd63\", \"filing_type\": \"Q4\", \"filing_type_display\": \"4th Quarter - Report\", \"filing_year\": 2012, \"filing_period\": \"fourth_quarter\", \"filing_period_display\": \"4th Quarter (Oct 1 - Dec 31)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/751ebd2d-e086-4c61-8bff-ca32dd4edd63/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"60000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Robert A. Russell, Partner\", \"dt_posted\": \"2013-01-19T22:13:20.820000-05:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": \"United States of America\", \"registrant_address_1\": \"601 Pennsylvania Avenue\", \"registrant_address_2\": \"Suite 210\", \"registrant_different_address\": false, \"registrant_city\": \"Washington\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20004\", \"registrant\": {\"id\": 400577737, \"url\": \"https://lda.senate.gov/api/v1/registrants/400577737/\", \"house_registrant_id\": null, \"name\": \"THE INGRAM GROUP LLC\", \"description\": \"strategic affairs firm\", \"address_1\": \"875 15th Street, NW Ste 600\", \"address_2\": null, \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20005\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"AMANDA BUNNING KELSEY\", \"contact_telephone\": \"+1 202-683-6833\", \"dt_updated\": \"2026-01-23T16:26:29.709092-05:00\"}, \"client\": {\"id\": 193009, \"url\": \"https://lda.senate.gov/api/v1/clients/193009/\", \"client_id\": 125, \"name\": \"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)\", \"general_description\": \"trade group representing U.S. pharmaceutical research and biotechnology companies\", \"client_government_entity\": false, \"client_self_select\": false, \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": null, \"ppb_state_display\": null, \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2011-02-22\"}, \"lobbying_activities\": [{\"general_issue_code\": \"CPT\", \"general_issue_code_display\": \"Copyright/Patent/Trademark\", \"description\": \"Issues related to the Patent Reform Act of 2011, S.23.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 51371, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"BERNARD\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"TOON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 51395, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ROBERT\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"RUSSELL\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 53557, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KYLE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SIMMONS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"Issues related to the implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012, Public Law No: 112-144.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 51371, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"BERNARD\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"TOON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 51395, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ROBERT\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"RUSSELL\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 53557, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KYLE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SIMMONS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MMM\", \"general_issue_code_display\": \"Medicare/Medicaid\", \"description\": \"Issues related to the Patient Protection and Affordable Care Act, P.L. 111-148: Medicare issues related to the Independent Payment Advisory Board (IPAB), Medicare funding issues, P.L. 112-25, the Budget Control Act of 2011 and the American Taxpayer Relief Act of 2012, H.R. 8.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 51371, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"BERNARD\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"TOON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 51395, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ROBERT\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"RUSSELL\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 53557, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KYLE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SIMMONS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"PHA\", \"general_issue_code_display\": \"Pharmacy\", \"description\": \"Issues related to pharmaceutical importation, generic drug pricing and the FAIR Generics Act, S.1882.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 51371, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"BERNARD\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"TOON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 51395, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ROBERT\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"RUSSELL\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 53557, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KYLE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SIMMONS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["751ebd2d-e086-4c61-8bff-ca32dd4edd63"], "units": {}, "query_ms": 1.867624931037426, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}